News & Events
November 30, 2023
2023 C-Path Neuroscience Annual MeetingC-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders together from both the Critical Path for Alzheimer’s Disease and the Critical Path for Parkinson’s consortia, this meeting will build off the recent advancements in drug development for Parkinson’s and Alzheimer’s, exploring important opportunities to apply lessons......
June 25, 2023 - June 29, 2023
DIA 2023 Global Annual Meeting | ILLUMINATEThe DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, key C-Path personnel will be on-hand to discuss and view the many different perspectives offered at this event, while highlights expertise across the globe to......
October 25, 2022 - October 27, 2022
2022 C-Path Neuroscience Annual MeetingC-Path’s Neuroscience Program (CPAD, CPP, CP-RND, CPTA, D-RSC, HD-RSC) is pleased to host the 2022 C-Path Neuroscience Annual Meeting, October 25-27, 2022 at The Westin Crystal City Reagan National Airport in Arlington, VA. The 2022 C-Path Neuroscience Annual Meeting will bring together global industry, academic and regulatory agency partners, colleagues and collaborators for an engaging,......
August 17, 2021
View Now | C-Path Neuroscience Program Webinar – NfL in Neurodegenerative Diseases
C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members, representatives and partners from pharmaceutical industries, academic experts, government and regulatory agencies, and patient advocacy groups.
October 27, 2020
Critical Path for Alzheimer’s Disease 2020 Annual Meeting and Regulatory Science Workshop – VirtualOctober 27, 2020 9:30 a.m. – 1:00 p.m. (US Eastern Time) The Critical Path for Alzheimer’s Disease (CPAD) is a Critical Path Institute public-private partnership aimed at generating actionable solutions and knowledge towards advancing drug development across the AD continuum. The key objectives of the meeting are: Scientific dialogue to guide the strategic development of......